Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 6200481989 ISBN 13: 9786200481986
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 67,77
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 84 pages. 8.66x5.91x0.19 inches. In Stock.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 6200481989 ISBN 13: 9786200481986
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Mergers and Acquisitions in the Healthcare Sector | Empirical Analysis of Shareholders' Value Creation | Dimitar Panchev | Taschenbuch | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9786200481986 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing Dez 2019, 2019
ISBN 10: 6200481989 ISBN 13: 9786200481986
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The healthcare sector has been increasingly growing in importance in the past two decades. Innovative drugs, advanced medical devices and more sophisticated hospital procedures have allowed patients to cope with and overcome previously incurable diseases and disabilities. However, this has come at a significant cost. Healthcare expenditure has increased substantially over the years, and according to the World Health Organization, it amounted to more than $7 trillion in 2015. Given these tremendous costs, it is important to understand whether the companies in this sector operate efficiently. One side of this is examining whether the transactions which they undertake actually create value. However, such corporate actions usually affect many different groups of stakeholders. For example, a merger of hospitals can directly affect the quality of care to patients, or the acquisition of a pharmaceutical company by its rival might lead to increases in the prices of life-saving medications. In this book we will take a higher-level view and explore the effects on shareholders of the companies involved in a deal. 84 pp. Englisch.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 6200481989 ISBN 13: 9786200481986
Anbieter: moluna, Greven, Deutschland
EUR 34,25
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Panchev DimitarThe author conducted the research in this book as part of his Master s Thesis at the University of St. Gallen. He had previously obtained Master s and Bachelor s Degrees from Bocconi University. Dimitar is now working .
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing Dez 2019, 2019
ISBN 10: 6200481989 ISBN 13: 9786200481986
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The healthcare sector has been increasingly growing in importance in the past two decades. Innovative drugs, advanced medical devices and more sophisticated hospital procedures have allowed patients to cope with and overcome previously incurable diseases and disabilities. However, this has come at a significant cost. Healthcare expenditure has increased substantially over the years, and according to the World Health Organization, it amounted to more than $7 trillion in 2015. Given these tremendous costs, it is important to understand whether the companies in this sector operate efficiently. One side of this is examining whether the transactions which they undertake actually create value. However, such corporate actions usually affect many different groups of stakeholders. For example, a merger of hospitals can directly affect the quality of care to patients, or the acquisition of a pharmaceutical company by its rival might lead to increases in the prices of life-saving medications. In this book we will take a higher-level view and explore the effects on shareholders of the companies involved in a deal.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 84 pp. Englisch.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 6200481989 ISBN 13: 9786200481986
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The healthcare sector has been increasingly growing in importance in the past two decades. Innovative drugs, advanced medical devices and more sophisticated hospital procedures have allowed patients to cope with and overcome previously incurable diseases and disabilities. However, this has come at a significant cost. Healthcare expenditure has increased substantially over the years, and according to the World Health Organization, it amounted to more than $7 trillion in 2015. Given these tremendous costs, it is important to understand whether the companies in this sector operate efficiently. One side of this is examining whether the transactions which they undertake actually create value. However, such corporate actions usually affect many different groups of stakeholders. For example, a merger of hospitals can directly affect the quality of care to patients, or the acquisition of a pharmaceutical company by its rival might lead to increases in the prices of life-saving medications. In this book we will take a higher-level view and explore the effects on shareholders of the companies involved in a deal.